These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7216154)

  • 41. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
    Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
    J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of hepatitis B virus in the liver by in situ hybridization (ISH) in HBsAg seropositive and seronegative patients.
    Caballero T; Caballero MA; Ruiz-Extremera A; Barrios del Pino Y; O'Valle F; Salmerón FJ; Sánchez Salgado G
    Histol Histopathol; 1995 Apr; 10(2):265-70. PubMed ID: 7599426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outbreaks of hepatitis B virus infection among hemodialysis patients-- California, Nebraska, and Texas, 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Apr; 45(14):285-9. PubMed ID: 8598825
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
    Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
    Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation.
    Segovia R; Sánchez-Fueyo A; Rimola A; Grande L; Bruguera M; Costa J; Soguero C; Uriz J
    Liver Transpl; 2001 Feb; 7(2):106-12. PubMed ID: 11172393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relative immunogenicity of hepatitis B virus-encoded antigens as targets for cytotoxic T-cell response.
    Ishikawa T; Kakumu S; Yoshioka K; Yamada M; Tanaka K; Higashi Y; Takayanagi M; Okumura A; Kojima A; Tamura T
    Immunology; 1993 Oct; 80(2):313-8. PubMed ID: 8262560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
    Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T lymphocyte-mediated cytotoxicity in HBsAg-positive liver disease.
    El Sheikh N; Osman CG; Cullens H; Eddleston AL; Williams R
    Clin Exp Immunol; 1978 Feb; 31(2):158-65. PubMed ID: 306323
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis b virus infection.
    Alberti A; Realdi G; Bortolotti F; Rigoli AM
    Gut; 1977 Dec; 18(12):1004-9. PubMed ID: 304824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymphocyte cytotoxicity for isolated hepatocytes in acute viral and chronic active hepatitis.
    Cochrane M; Eddleston A; Williams R
    Minerva Med; 1978 Aug; 69(38):2543-8. PubMed ID: 714256
    [No Abstract]   [Full Text] [Related]  

  • 51. T-lymphocyte number and function and the course of hepatitis B in hemodialysis patients.
    De Gast GC; Houwen B; van der Hem GK; The TH
    Infect Immun; 1976 Nov; 14(5):1138-43. PubMed ID: 1086288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Active rosette-forming lymphocytes in chronic hepatitis.
    Stanciu L; Urcan S; Părău N; Radu D; Popescu S
    Med Interne; 1982; 20(4):277-82. PubMed ID: 6985551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg positive chronic liver disease.
    Mieli-Vergani G; Vergani D; Portmann B; White Y; Murray-Lyon I; Marigold JH; Woolf I; Eddleston AL; Williams R
    Gut; 1982 Dec; 23(12):1029-36. PubMed ID: 6983473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell-mediated cytotoxicity to autologous hepatocytes in HBsAg positive liver disease: an analysis of the killing specificity and of the clinical use of the test.
    Actis GC; Touscoz GA; Crivelli O; Rizzetto M; Rocca B; Poli G; Verme G
    Boll Ist Sieroter Milan; 1984 Mar; 63(1):19-29. PubMed ID: 6206876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymphocytotoxic HLA antibodies and HB infection in transfused hemodialysis patients waiting for kidney transplantation.
    Adorno D; Valeri M; Piazza A; Bonini S; Papola F; Casciani CU
    Transplant Proc; 1979 Jun; 11(2):1269-70. PubMed ID: 382505
    [No Abstract]   [Full Text] [Related]  

  • 56. Cytotoxicity by NK-like cells from hepatitis B-immune patients to a human hepatoma cell line secreting HBsAg.
    Chin TW; Hollinger FB; Rich RR; Troisi CL; Dreesman GR; Melnick JL
    J Immunol; 1983 Jan; 130(1):173-80. PubMed ID: 6292302
    [No Abstract]   [Full Text] [Related]  

  • 57. Cell mediated cytotoxicity to autologous hepatocytes in hepatitis B virus infection: facts, limits and relevance.
    Boltz-Nitulescu G; Penner E; Gangl A
    Z Gastroenterol; 1985 Apr; 23(4):188-91. PubMed ID: 2414933
    [No Abstract]   [Full Text] [Related]  

  • 58. [Infection caused by hepatitis B virus in a hemodialysis unit. Its epidemiologic importance. Diagnosis and prognosis].
    Findor JA; Casadei DH; Bruch Igartúa EM; Cambariere R; Domecq R; Najum Zarazaga CJ; Lafage M; Domecq P; Leanza H; Elsner B; Avagnina MA; Vila ND
    Acta Gastroenterol Latinoam; 1981; 11(1):1-35. PubMed ID: 7034438
    [No Abstract]   [Full Text] [Related]  

  • 59. [Immune response and the dynamics of the cytolysis syndrome in viral hepatitis A and B].
    Beksler KhM; Osna NA; Novitskii IN; Titovskiĭ VI; Bachinskaia MK
    Ter Arkh; 1986; 58(10):27-8. PubMed ID: 3492059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies in homosexual patients with and without lymphadenopathy. Relationships to the acquired immune deficiency syndrome.
    deShazo RD; Penico JP; Pankey GA; Nordberg JA; Newton JL; Bozelka B; Cortez LM; Dalovisio JR
    Arch Intern Med; 1984 Jun; 144(6):1153-8. PubMed ID: 6610398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.